iiinova — where your digital self keeps evolving

perturbai.bsky.social

@perturb.ai

perturbai.bsky.social @perturb.ai · 24/03/2026

The need for causal data is clear: the brain is one of the most complex systems, unlocking this biology requires massively multiplexed gene perturbation directly within its native context. This is the future of scalable drug discovery. #SystemsBiology #CRISPR #AI #BiotechInnovation

001

perturbai.bsky.social @perturb.ai · 24/03/2026

By combining this causal biology with machine learning, we can begin to: • model more accurate disease systems • simulate better therapeutic interventions • identify targets with higher translational potential

101

perturbai.bsky.social @perturb.ai · 24/03/2026

PerturbAI’s platform measures gene function directly in intact organisms, allowing us to capture actual biological circuitry instead of simplified models.

101

perturbai.bsky.social @perturb.ai · 24/03/2026

Why does in vivo CRISPR matter? Much of biology has historically been studied in simplified systems: isolated cells or artificial environments. But disease doesn’t happen in isolation. It happens inside complex biological circuits and across tissues and cell types.

100

perturbai.bsky.social @perturb.ai · 19/03/2026

We are utilizing our in vivo CRISPR platform and causal AI models to develop best-in-class therapeutics for complex metabolic and chronic diseases.

000

perturbai.bsky.social @perturb.ai · 19/03/2026

Our platform, the engine behind the world’s largest in vivo CRISPR atlas, was featured in a keynote at NVIDIA GTC this week. Read more about our collaboration here: lnkd.in/dqzmFUYH #AI #CRISPR #DrugDevelopment #Innovation #Genomics

110

perturbai.bsky.social @perturb.ai · 18/03/2026

This important milestone follows our launch from stealth yesterday, with the public release of our landmark dataset to accelerate biology and medicine.

000

perturbai.bsky.social @perturb.ai · 18/03/2026

The work reveals insights into the genetics and mechanisms of diseases in vivo, paving the way for novel therapeutic discovery grounded in human genetics and causal biology.

100

perturbai.bsky.social @perturb.ai · 18/03/2026

We’re excited to share that the manuscript detailing PerturbAI’s largest brain-wide in vivo CRISPR atlas is now live on bioRxiv. Read the manuscript here: lnkd.in/djGN53Kz #CRISPR #AI #DrugDiscovery #FunctionalGenomics #Biotech

110

perturbai.bsky.social @perturb.ai · 17/03/2026

By combining scalable in vivo CRISPR perturbation with AI, we model biological systems at unprecedented resolution and simulate therapeutic interventions before committing to expensive downstream development. #CRISPR #AI #DrugDiscovery #FunctionalGenomics #Biotech

000

perturbai.bsky.social @perturb.ai · 17/03/2026

This dataset represents a new category of biological data: organism-level, circuit-resolved causal genomics leading to novel targets and therapeutics.

100

perturbai.bsky.social @perturb.ai · 17/03/2026

Introducing PerturbAI. Today we announced our emergence from stealth with the release of the world’s largest in vivo CRISPR data engine, interrogating thousands of genetic perturbations across 8 million cells throughout the whole brain. Read More: perturb.ai/news

perturb.ai

News | Explore Cutting-Edge Gene Editing Technologies — PerturbAI

Discover the latest updates and breakthroughs in gene editing with PerturbAI's news on CRISPR innovations and collaborations. Stay informed today.

142